[AsCNP_P16] Poster Session 16
Neurological Disorders

Fri. Oct 11, 2019 1:40 PM - 3:10 PM Poster Hall (Multi-purpose Hall)

Chair: ‌Kazuki NAGAYASU (Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, Japan)

+Add all to schedule

1:40 PM - 1:45 PM

[AsCNP-P16-1] Hippocampal neuronal excitability in dopamine deficient mice during hyperlocomotor activity caused by novel environment exposure

^○Masayo FUJITA¹, Yukiko OCHIAI^{1, 2}, Taishi Clark TAKEDA¹, Yoko HAGINO¹, Kazuto KOBAYASHI³, Kazutaka IKEDA¹ (1. Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, 2. Department of Neurology, Tokyo Metropolitan Neurological Hospital, 3. Department of Molecular Genetics, Institute of Biomedical Sciences, Fukushima Medical University )

1:45 PM - 1:50 PM

[AsCNP-P16-2] KCC2, a K⁺-Cl^- co-transporter, is a possible target to attenuate the neuronal dysfunction that is associated with radiation therapy for brain tumor

^○Kento IGARASHI^{1, 2}, Kazuo TOMITA^{1, 2}, Koh-ichi TANAKA^{1, 2}, Yoshikazu KUWAHARA^{1, 3}, Nobuyoshi NISHIYAMA², Akihiro KURIMASA³, Tomoaki SATO¹ (1. Lab. of applied phapharmacology, Graduate school of medical and dental sciences, Kagoshima University, Kagoshima, Japan, 2. Department of Pharmacy, School of Pharmacy, Hyogo University of Health Sciences, Kobe, Japan, 3. Department of Radiation Biology and Medicine, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan)

1:50 PM - 1:55 PM

[AsCNP-P16-3] Analysis of the effects of serotonin related drugs on hyperlocomotion in dopamine-deficient mice

^○Yukiko OCHIAI^{1, 2}, Masayo FUJITA¹, Yoko HAGINO¹, Kazuto KOBAYASHI³, Ryoichi OKIYAMA², Kazutaka IKEDA¹ (1. Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, 2. Department of Neurology, Tokyo Metropolitan Neurological Hospital, 3. Department of Molecular Genetics, Institute of Biomedical Sciences, Fukushima Medical University)

1:55 PM - 2:00 PM

[AsCNP-P16-4] Functional roles of glutamate transporter in neurodevelopmental processes

^○Mizuki UCHIDA¹, Erika OTA¹, Akira YOSHIMI¹, Shinji KITAGAKI², Norio OZAKI³, Tomomi AIDA⁴, Kohichi TANAKA⁴, Yukihiro NODA¹ (1. Division of Clinical Sciences and Neuropsychopharmacology, Faculty of Pharmacy, Meijo University, Nagoya, Japan, 2. Medicinal Chemistry, Meijo University Faculty of Pharmacy, Nagoya, Japan, 3. Department of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan, 4. Laboratory of Molecular Neuroscience, Medical Research Institute, Tokyo Medical and Dental University (TMD), Tokyo, Japan)

2:00 PM - 2:05 PM

[AsCNP-P16-5] The deficit of quinolinic acid phosphoribosyltransferase induces hypolocomotion and cognitive impairment through impairment of dopaminergic neuronal function

^○Moe NIIJIMA¹, Akihiro MOURI^{1, 4}, Tomoaki TESHIGAWARA², Kazuo KUNISAWA¹, Hisayoshi KUBOTA¹, Mami HIRAKAWA¹, Yuko MORI², Masato HOSHI², Yasuko YAMAMOTO², Toshitaka NABESHIMA^{3, 4}, Kuniaki SAITO^{2, 4} (1. Department of Regulatory Science for Evaluation & Development of Pharmaceuticals & Devices, Fujita Health University Graduate School of Health Science, 2. Department of Disease Control and Prevention, Fujita Health University Graduate School of Health Sciences, 3. Advanced Diagnostic System Research Laboratory, Fujita Health University Graduate School of Health Sciences, 4. Japanese Drug Organization of Appropriate Use and Research)

2:05 PM - 2:10 PM

[AsCNP-P16-6] Dopaminergic modulation of α7 nicotinic acetylcholine receptor-mediated tremor in mice

^○Masaki KATO, Naofumi KUNISAWA, Saki SHIMIZU, Yuika ISHIKURA, Natsuki HIRATA, Mizuki YASUNAGA, Yukihiro OHNO (Dept. Pharmacol., Osaka Univ. Pharm. Sci., Osaka, Japan)

2:10 PM - 2:15 PM

[AsCNP-P16-7] Involvement of region-specific glial dysfunction in rotenone neurotoxicity

^○Ikuko MIYAZAKI¹, Masato ASANUMA¹, Shinki MURAKAMI¹, Ryo KIKUOKA^{1, 2}, Nami ISOOKA¹, Chiharu SOGAWA³, Norio SOGAWA⁴, Yoshihisa KITAMURA² (1. Dept. of Med. Neurobiol., Okayama Univ. Grad. Sch. of Med., Dent. & Pharmaceut. Sci., 2. Dept. of Clin. Pharm., Okayama Univ. Grad. Sch. of Med., Dent. & Pharmaceut. Sci., 3. Dept. of Dent. Pharmacol., Okayama Univ. Grad. Sch. of Med., Dent. & Pharmaceut. Sci., 4. Dept. of Dent. Pharmacol., Matsumoto Dent. Univ.)